Lv71
4390 积分 2021-03-17 加入
Nucleic Acid–Based Therapies — The Next Frontier in Treating Dyslipidemias
5天前
已关闭
siRNAs targeting ANGPTL3 for mixed dyslipidemia
5天前
已完结
Future of angiopoietin-like protein 3 inhibitors as a therapeutic agent
5天前
已完结
Does siRNA therapy against ANGPTL3 bring new hope in homozygous familial hypercholesterolaemia?
5天前
已关闭
PCSK9 and ANGPTL3 Inhibitors in Homozygous Familial Hypercholesterolemia: A Meta-analysis of Randomized Clinical Trials
5天前
已完结
Effects of a Novel Dual Phosphodiesterase 3 and 4 Inhibitor TQC3721 in Patients with COPD in China (PACER-II): a phase 2, multicentre, randomised, double-blind, placebo-controlled trial
1个月前
已完结
Is Target-Based Drug Discovery Efficient? Discovery and “Off-Target” Mechanisms of All Drugs
1个月前
已完结
Iptacopan: First Approval
1个月前
已完结
A Urinary Peptide From Complement Factor B Alleviates Diabetic Renal Fibrosis by Inhibiting the HIF ‐1α‐Driven Glycolysis Pathway
1个月前
已完结
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
皖公网安备34019202002308
